Journal of International Oncology ›› 2020, Vol. 47 ›› Issue (1): 35-38.doi: 10.3760/cma.j.issn.1673-422X.2020.01.006
• Reviews • Previous Articles Next Articles
Received:
2019-12-06
Revised:
2019-12-13
Online:
2020-01-08
Published:
2020-03-22
Contact:
Huang Junxing
E-mail:hjxtz@sina.cn
Supported by:
Li Xing, Huang Junxing. Role of lncRNA MEG3 as ceRNA of miR-21 in cancer[J]. Journal of International Oncology, 2020, 47(1): 35-38.
[1] | Bray F, Ferlay J, Soerjomataram I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. DOI: 10.3322/caac.21492. |
[2] | Salmena L, Poliseno L, Tay Y , et al. A ceRNA hypojournal: the Rosetta Stone of a hidden RNA language?[J]. Cell, 2011,146(3):353-358. DOI: 10.1016/j.cell.2011.07.014. |
[3] | Greife A, Knievel J, Ribarska T , et al. Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinoma[J]. Clin Epigenetics, 2014,6(1):29. DOI: 10.1186/1868-7083-6-29. |
[4] | Cui X, Jing X, Long C , et al. Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis[J]. Oncotarget, 2017,8(12):19049-19056. DOI: 10.18632/oncotarget.14987. |
[5] | Zhang J, Lin Z, Gao Y , et al. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer[J]. J Exp Clin Cancer Res, 2017,36(1):5. DOI: 10.1186/s13046-016-0472-2. |
[6] | Guo W, Dong Z, Liu S , et al. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma[J]. Mol Carcinog, 2017,56(8):1924-1934. DOI: 10.1002/mc.22650. |
[7] | Gao Y, Huang P, Zhang J . Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma[J]. J Transl Med, 2017,15(1):268. DOI: 10.1186/s12967-017-1372-8. |
[8] | Ivo D'Urso P, Fernando D'Urso O, Damiano Gianfreda C , et al. miR-15b and miR-21 as circulating biomarkers for diagnosis of glioma[J]. Curr Genomics, 2015,16(5):304-311. DOI: 10.2174/1389202916666150707155610. |
[9] | Han JG, Jiang YD, Zhang CH , et al. A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer[J]. Ann Surg Treat Res, 2017,92(2):55-66. DOI: 10.4174/astr.2017.92.2.55. |
[10] | Zhang CY, Yu MS, Li X , et al. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway[J]. Tumour Biol, 2017,39(6):1010428317701311. DOI: 10.1177/1010428317701311. |
[11] | Zhu M, Wang X, Gu Y , et al. MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway[J]. Arch Biochem Biophys, 2019,661:22-30. DOI: 10.1016/j.abb.2018.10.021. |
[12] | Zhang J, Yao T, Wang Y , et al. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21[J]. Cancer Biol Ther, 2016,17(1):104-113. DOI: 10.1080/15384047.2015.1108496. |
[13] | Ferlay J, Soerjomataram I, Dikshit R , et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015,136(5):E359-E386. DOI: 10.1002/ijc.29210. |
[14] | Dan J, Wang J, Wang Y , et al. LncRNA-MEG3 inhibits proliferation and metastasis by regulating miRNA-21 in gastric cancer[J]. Biomed Pharmacother, 2018,99:931-938. DOI: 10.1016/j.biopha.2018.01.164. |
[15] | He Z, Dong W, Li Q , et al. Sauchinone prevents TGF-β-induced EMT and metastasis in gastric cancer cell[J]. Biomed Pharmacother, 2018,101:355-361. DOI: 10.1016/j.biopha.2018.02.121. |
[16] | Xu G, Meng L, Yuan D , et al. MEG3/miR-21 axis affects cell mobility by suppressing epithelial mesenchymal transition in gastric cancer[J]. Oncol Rep, 2018,40(1):39-48. DOI: 10.3892/or.2018.6424. |
[17] | Siegel R, Ma J, Zou Z , et al. Cancer statistics, 2014[J]. CA Cancer J Clin, 2014,64(1):9-29. DOI: 10.3322/caac.21208. |
[18] | Mizugaki H, Fujiwara Y, Yamamoto N , et al. Adjuvant chemotherapy in patients with completely resected small cell lung cancer: a retrospective analysis of 26 consecutive cases[J]. Jpn J Clin Oncol, 2014,44(9):835-840. DOI: 10.1093/jjco/hyu092. |
[19] | Wang P, Chen D, Ma H , et al. LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis[J]. Onco Targets Ther, 2017,10:5137-5149. DOI: 10.2147/OTT.S146423. |
[20] | Oh KY, Hong KO, Huh YS , et al. Decreased expression of SOX7 induces cell proliferation and invasion and correlates with poor prognosis in oral squamous cell carcinoma[J]. J Oral Pathol Med, 2017,46(9):752-758. DOI: 10.1111/jop.12566. |
[21] | Man CH, Fung TK, Wan H , et al. Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia[J]. Blood, 2015,125(25):3928-3936. DOI: 10.1182/blood-2014-06-580993. |
[22] | Zhao T, Yang H, Tian Y , et al. SOX7 is associated with the suppression of human glioma by HMG-box dependent regulation of Wnt/β-catenin signaling[J]. Cancer Lett, 2016,375(1):100-107. DOI: 10.1016/j.canlet.2016.02.044. |
[23] | Han L, Wang W, Ding W , et al. MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7[J]. J Cell Mol Med, 2017,21(9):2000-2008. DOI: 10.1111/jcmm.13120. |
[24] | Jabbour E, Kantarjian H . Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management[J]. Am J Hematol, 2014,89(5):547-556. DOI: 10.1002/ajh.23691. |
[25] | Li Z, Yang L, Liu X , et al. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21[J]. Biomed Pharmacother, 2018,104:181-192. DOI: 10.1016/j.biopha.2018.05.047. |
[26] | Li N, Zheng B, Cai HF , et al. Cost effectiveness of imatinib, dasatinib, and nilotinib as first-line treatment for chronic-phase chronic myeloid leukemia in China[J]. Clin Drug Investig, 2018,38(1):79-86. DOI: 10.1007/s40261-017-0587-z. |
[27] | Zhou X, Yuan P, Liu Q , et al. LncRNA MEG3 regulates imatinib resistance in chronic myeloid leukemia via suppressing microRNA-21[J]. Biomol Ther (Seoul), 2017,25(5):490-496. DOI: 10.4062/biomolther.2016.162. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[5] | Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[6] | Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[7] | Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[8] | Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[9] | Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[11] | Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||